Primary Sclerosing Cholangitis in Children | MicrobiomeTrials← Back to trialsNCT04181138
Primary Sclerosing Cholangitis in Children
RecruitingOBSERVATIONAL
Trial Details
Start: 2021-12-30Est. Completion: 2029-05-31
Enrollment target: 1,000 participants Locations- Children's Hospital of Los Angeles, Los Angeles, California, United States
- Children's Hospital Colorado, Aurora, Colorado, United States
- Children's Healthcare of Atlanta, Atlanta, Georgia, United States
- Ann & Robert H Lurie Children's Hospital, Chicago, Illinois, United States
- Riley Hospital for Children, Indianapolis, Indiana, United States
- Cincinnati Children's Hospital Medical, Cincinnati, Ohio, United States
- The Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, United States
- UPMC Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania, United States
- Texas Children's Hospital (Baylor College of Medicine), Houston, Texas, United States
- The University of Utah, Salt Lake City, Utah, United States
- Seattle Children's Hospital, Seattle, Washington, United States
- The Hospital for Sick Children, Toronto, Ontario, Canada
Other microbiome trials you might be interested in
Primary Sclerosing Cholangitis
This study is a clinical trial being done to investigate the efficacy of drug BRS201 (hydroxocobalamin) as a treatment i…
Chestnut Hill, United StatesEst. completion May 1, 2027
Primary Sclerosing Cholangitis
Background:
Primary sclerosing cholangitis is a rare chronic liver disease. It affects the bile ducts of the
liver. It…
Bethesda, United StatesEst. completion Oct 31, 2026
Contact
Recruiting
Primary Sclerosing CholangitisLiver Transplant, ComplicationsPSCBiliary Strictures
This study aims to determine the efficacy of 36 months once-daily fenofibrate in preventing clinically-detectable recurr…
Scottsdale, United StatesEst. completion Mar 30, 2028